Jan Van Tornout

Efficacy and safety of dasatinib in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blast phase

Jörge E. Cortes, D-W Kim, Emmanuel Raffoux et al. · Leukemia · 2008 · 201 citations

Medicine, Pharmacology, Pharmacotherapy +8

Dasatinib in the Treatment of Chronic Myeloid Leukemia in Accelerated Phase After Imatinib Failure: The START A Trial

Jane F. Apperley, Jörge E. Cortes, Dong‐Wook Kim et al. · Journal of Clinical Oncology · 2009 · 196 citations · Full text

Medicine, Hematology, Pharmacology +11

Congenital folate malabsorption

L. Corbeel, Greet Van den Berghe, J. Jaeken et al. · European Journal of Pediatrics · 1985 · 72 citations

Phase 2 study evaluating intermittent and continuous linsitinib and weekly paclitaxel in patients with recurrent platinum resistant ovarian epithelial cancer

Amit M. Oza, Stanley B. Kaye, Jan Van Tornout et al. · Gynecologic Oncology · 2018 · 34 citations · Full text

Medicine, Oncology, Pharmacology +16

Efficacy of Dasatinib in Patients with Philadelphia-Chromosome-Positive Acute Lymphoblastic Leukemia Who Are Resistant or Intolerant to Imatinib: 2-Year Follow-Up Data from START-L (CA180-015).

Kimmo Porkka, Bengt Simonsson, Hervé Dombret et al. · Blood · 2007 · 28 citations

Medicine, Hematology, Oncology +8